BSX

Boston Scientific Corporation

Healthcare
48.37 +0.29 +0.60% Pre-Market
2026-09-02 • USD

Key Metrics

Market Cap 70.10B
EV 82.18B
Shares Out 1.45B
Revenue (ttm) 21.00B
Net Income 3.67B
Beta —
P/E —
Forward P/E —
EPS (ttm) $2.47
P/S 3.39
P/B 2.85
P/FCF 19.62
P/C 15.70
EV/Sales 3.91
EV/EBITDA 15.12
ROA 8.36%
ROE 15.21%
ROIC 10.5%
Gross Margin 69.93%
Oper. Margin 19.78%
Profit Margin 17.5%
Debt/Eq 0.51
LT Debt/Cap 30.45%
Quick Ratio 0.56
Current Ratio 1.24
Book/sh 16.96
Cash/sh 0.37
Div Yield —
Div TTM —
Payout Ratio —
SMA20 -2.69%
SMA50 3.43%
SMA200 -28.14%
Volume 17,010,501
Avg Volume 20.34M
Rel Volume 0.84
Perf Week 3.02%
Perf Month -0.72%
Perf Quarter 0.82%
Perf Half Y -34.90%
Perf YTD -49.58%
Perf Year -55.29%
Perf 3Y -10.33%
Perf 5Y 7.03%

Factor Lens

Seasonal Performance

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. The company…

Name
Boston Scientific Corporation
Industry
Medical Devices
CEO
Michael F. Mahoney · Chairman of the Board of Directors, President and Chief Executive Officer
Employees
59,000 as of 2025-12-31
IPO Date
2020-06-18
Phone
(508) 683-4000
Address
300 Boston Scientific Way, Marlborough, MA 01752-1234
Website
www.bostonscientific.com

Key Executives

Name Title FY Pay
Michael F. Mahoney Chairman of the Board of Directors, President and Chief Executive Officer —

Latest News

Related stocks

Other companies in the same sector on MarketWalks.